Skip to content
Wednesday 2 September 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,789.28
-0.32%
DAX
25,970.11
-1.10%
CAC 40
8,301.85
0.00%
STOXX 50
6,368.98
-0.80%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Monday 14 December 2020 6:58 am

GPs to begin offering coronavirus vaccines from today

By: Edward Thicknesse

Add as a preferred source on Google
GPs across England will begin administering coronavirus vaccinations today as the next stage of the vaccine rollout gets under way.
GPs will begin administering the Pfizer/Biontech vaccine today as the UK's vaccine rollout continues.

GPs across England will begin administering coronavirus vaccinations today as the next stage of the vaccine rollout gets under way.

The NHS said that GP surgeries in 100 locations would receive doses of the vaccine today, with some expected to begin inoculations this afternoon.

A majority, however, are expected to begin offering the treatment from tomorrow instead, prioritising over 80s and healthcare staff.

Since the historic rollout began last week, tens of thousands of people have already received the Pfizer/Biontech vaccine.

Later this week care homes around the country will start receiving their doses of the vaccine.

Although care homes are the government’s highest priority, inoculations have been delayed because of logistical difficulties with the vaccine, which needs to be stored at -70 degrees.

The second stage in the rollout comes after the UK recorded an extra 18,447 cases of coronavirus on Sunday, with 144 new deaths.

Over the weekend, hopes were raised that Oxford University’s vaccine – developed in partnership with Astrazeneca – could be available by the end of the year.

Speaking on the Andrew Marr Show, the vaccine’s lead researcher Sarah Gilbert said there was a “pretty high” chance of certain groups receiving the treatment in that timeframe.

The government has already bought 100m doses of the treatment, 5m of which are already available for use.

Read more

ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Morning Wire Content

Related Topics

  • Coronavirus

Trending Articles

  • Vodafone and Deliveroo look to patch up Reform ties after Yusuf prison threats

  • Jaguar reveals the Type 01’s screen-free interior

  • Trio of firms poised to quit London Stock Exchange as exodus gathers pace

  • Easyjet’s over-60s recruitment push is economically necessary

  • As it happened: FTSE 100 slides as bound rout deepens; Oil jumps as Trump vows more strikes on Iran

More from Morning Wire

  • ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

    Business Wire
  • Nex Playground Announces Global Expansion at gamescom 2026, Launching in Germany Later This Year

    Business Wire
  • Citi Unveils Custody+: A Suite of Near- and Real-time Custody Solutions to Meet Always-On Industry Demand

    Business Wire
  • Dolly Parton: The rhinestone capitalist

    Opinion
    Dollywood gift shop with Dolly Parton t-shirt, books, mugs, and colorful floral display. A person browses merchandise.
  • Manchester billionaire tables £583m offer for property developer Harworth

    Property
    Harworth Group building exterior with a brick facade and prominent entrance under a blue sky
  • ‘Absurd’: Government seeks quantum tech chief – no experience necessary

    Tech
    Advanced quantum computer with intricate circuits and glowing interface, illustrating cutting-edge technology innovations
  • UK fintech Allica Bank looks to crack European market

    Fintech
    London rail infrastructure and urban development captured in partnership with Allica Bank, showcasing modern transportatio...
  • Aviva profits jump following Direct Line acquisition

    Insurance
    Aviva's deal to buy Direct Line was agreed in March
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook